TITLE-ABS-KEY("GLP-1 receptor agonist" OR "semaglutide" OR "liraglutide" OR "dulaglutide" OR "exenatide" OR "albiglutide" OR "efpeglenatide" OR "cotadutide" OR "lixisenatide") AND TITLE-ABS-KEY("type 2 diabetes" OR "T2DM") AND TITLE-ABS-KEY("MACE" OR "major adverse cardiovascular events" OR "cardiovascular outcomes" OR "myocardial infarction" OR "stroke" OR "cardiovascular death"). Here, GLP1R is linked to type 2 diabetes mellitus.